SAN DIEGO (BUSINESS WIRE) #CRISPR Today, Cardea Bio, Inc. - the world’s only mass producer of biocompatible semiconductors - announced a significant milestone with the launch of CRISPR QC Inc. as a separate business using Cardea’s CRISPR-chip™ technology for a range of quality control services for CRISPR gene edi.
/PRNewswire/ Today, Cardea Bio, Inc. - the world s only mass producer of biocompatible semiconductors - announced a collaboration agreement with Siemens.
/PRNewswire/ To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit).
/PRNewswire/ To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit).